Hanan M. A. El Henafy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hanan M. A. El Henafy has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Eman Mohamad El Nashar
Department of Anatomy, College of Medicine, King Khalid University, Abha, Saudi Arabia
5 shared publications - Hind Zafrah
Department of Physiology, Faculty of Medicine, King Khalid University, Abha, Saudi Arabia
4 shared publications - Heba Muhammed Ali Khalil
Department of Veterinary Hygiene and Management, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
3 shared publications - Alaa F. Bakr
Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
2 shared publications - Alshehri Hanan Hassan
Endocrinology and Diabetes Section, Internal Medicine Department, College of Medicine, King Khalid University, Abha, Saudi Arabia
2 shared publications - Islam Ahmed Khalil
Department of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University of Science and Technology (MUST), Giza 12582, Egypt
2 shared publications
Latest Publications
- 13 February 2026
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (6) , 4214-4239
Omega 3 Fatty Acids Mitigate Monosodium Glutamate (MSG)-Induced Developmental Toxicity via Hepcidin/NF-κB Pathway Modulation and Iron Homeostasis Restoration in Male Rats
- 13 February 2026
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (6) , 4214-4239
Omega 3 Fatty Acids Mitigate Monosodium Glutamate (MSG)-Induced Developmental Toxicity via Hepcidin/NF-κB Pathway Modulation and Iron Homeostasis Restoration in Male Rats
- 17 November 2025
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (1) , 238-259
Maternal monosodium glutamate exposure disrupts leptin and insulin signaling in the hypothalamus, activating NF-κB and mTOR inflammatory pathways, contributing to metabolic dysfunction in male offspring
Background Maternal nutrition during critical developmental windows is increasingly recognised as a key determinant of offspring health, a concept central to the developmental origins of health and disease paradigm. Monosodium glutamate (MSG), a common food additive and neuroendocrine stimulant, warrants investigation in this context. Methods The impact of maternal MSG exposure (120 mg/kg) during gestation and/or lactation on metabolic programming in first-generation male rat offspring. Metabolic, hormonal, and molecular parameters in pups following maternal MSG administration, body weight, food intake, adiposity, glucose homeostasis (insulin sensitivity and resistance), lipid profiles, oxidative stress markers, and inflammatory mediators were measured. Furthermore, we analyzed microRNA expression profiles in relevant tissues. Results Maternal MSG exposure resulted in significant metabolic perturbations in offspring. Key findings included a reduced survival index, impaired glucose homeostasis (manifesting as decreased insulin sensitivity and increased insulin resistance), increased body weight, and elevated adiposity. We observed elevated oxidative stress, dyslipidemia, altered lipid peroxidation, and hormonal imbalances. Quantitative PCR analysis revealed altered expression of metabolic and inflammatory genes in both adipocytes and the hypothalamus. MicroRNA expression analysis identified significant alterations in miR-27a, miR-34a, miR-335, and miR-30a, suggesting potential regulatory roles in adipogenesis and metabolic control. Conclusions Maternal MSG exposure during gestation and lactation induces profound and adverse metabolic effects in male offspring. The observed alterations in metabolic indices suggest an increased risk of metabolic disease later in life. This study underscores the critical importance of maternal nutrition during sensitive developmental periods and has implications for public health recommendations and nutritional guidelines (Graphical abstract).
- 17 November 2025
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (1) , 238-259
Maternal monosodium glutamate exposure disrupts leptin and insulin signaling in the hypothalamus, activating NF-κB and mTOR inflammatory pathways, contributing to metabolic dysfunction in male offspring
Background Maternal nutrition during critical developmental windows is increasingly recognised as a key determinant of offspring health, a concept central to the developmental origins of health and disease paradigm. Monosodium glutamate (MSG), a common food additive and neuroendocrine stimulant, warrants investigation in this context. Methods The impact of maternal MSG exposure (120 mg/kg) during gestation and/or lactation on metabolic programming in first-generation male rat offspring. Metabolic, hormonal, and molecular parameters in pups following maternal MSG administration, body weight, food intake, adiposity, glucose homeostasis (insulin sensitivity and resistance), lipid profiles, oxidative stress markers, and inflammatory mediators were measured. Furthermore, we analyzed microRNA expression profiles in relevant tissues. Results Maternal MSG exposure resulted in significant metabolic perturbations in offspring. Key findings included a reduced survival index, impaired glucose homeostasis (manifesting as decreased insulin sensitivity and increased insulin resistance), increased body weight, and elevated adiposity. We observed elevated oxidative stress, dyslipidemia, altered lipid peroxidation, and hormonal imbalances. Quantitative PCR analysis revealed altered expression of metabolic and inflammatory genes in both adipocytes and the hypothalamus. MicroRNA expression analysis identified significant alterations in miR-27a, miR-34a, miR-335, and miR-30a, suggesting potential regulatory roles in adipogenesis and metabolic control. Conclusions Maternal MSG exposure during gestation and lactation induces profound and adverse metabolic effects in male offspring. The observed alterations in metabolic indices suggest an increased risk of metabolic disease later in life. This study underscores the critical importance of maternal nutrition during sensitive developmental periods and has implications for public health recommendations and nutritional guidelines (Graphical abstract).
- 2 September 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (7) , 1-19
Zinc oxide nanoparticles exposure disrupts brain redox-inflammatory-epigenetic axis and impairs PI3K/Akt survival pathway in male offspring
Widespread use of Zinc Oxide Nanoparticles (ZnO NPs) raises concerns about potential health risks, particularly following maternal exposure during critical developmental windows. The impact of exposure on offspring brain development remains unclear. The work aims to investigate the neurodevelopmental consequences of maternal ZnO NP exposure during gestation, lactation, or both periods in male rat offspring. Pregnant rats were administered ZnO NPs (< 100 nm) or vehicle. Offspring developmental parameters and brain tissues were analyzed at postnatal day 60. Assessments included oxidative stress markers (8-OHdG, MDA, NO), antioxidant (GSH, GST, GPX, SOD, CAT), cholinergic function (AChE), epigenetic markers (DNA methylation, BDNF promoter methylation, miR-34a, miR-29b), neurodegeneration-associated proteins (Aβ1–42, Tau), survival/inflammatory signaling pathways (p-Akt, PI3K mRNA, ERK, Bcl-2, COX2, IL-1β, TNF-α, IL-2, TGF-β), apoptosis (Caspase-3), BDNF mRNA, and brain histology. Maternal ZnO NP exposure significantly reduced offspring brain weight, body weight, and survival index, particularly following combined gestational and lactational exposure. Exposed offspring brains exhibited increased oxidative stress, depleted antioxidant defenses, impaired AChE activity, global DNA hypomethylation with targeted BDNF promoter hypermethylation (correlating with reduced BDNF mRNA), increased Aβ1–42 and Tau accumulation, suppressed PI3K/p-Akt and ERK survival signaling, elevated pro-inflammatory markers (IL-1β, TNF-α, IL-2, COX2, TGF-β), increased apoptosis (Caspase-3) alongside decreased Bcl-2, and dysregulated miRNA expression (increased miR-34a, decreased miR-29b). Histology confirmed duration-dependent neuronal damage. Maternal ZnO NP exposure induces persistent offspring neurotoxicity via oxidative stress, neuroinflammation, apoptosis, and epigenetic dysregulation. This highlights developmental brain vulnerability and the importance of assessing maternal nanoparticle exposure. Graphical abstract
- 2 September 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (7) , 1-19
Zinc oxide nanoparticles exposure disrupts brain redox-inflammatory-epigenetic axis and impairs PI3K/Akt survival pathway in male offspring
Widespread use of Zinc Oxide Nanoparticles (ZnO NPs) raises concerns about potential health risks, particularly following maternal exposure during critical developmental windows. The impact of exposure on offspring brain development remains unclear. The work aims to investigate the neurodevelopmental consequences of maternal ZnO NP exposure during gestation, lactation, or both periods in male rat offspring. Pregnant rats were administered ZnO NPs (< 100 nm) or vehicle. Offspring developmental parameters and brain tissues were analyzed at postnatal day 60. Assessments included oxidative stress markers (8-OHdG, MDA, NO), antioxidant (GSH, GST, GPX, SOD, CAT), cholinergic function (AChE), epigenetic markers (DNA methylation, BDNF promoter methylation, miR-34a, miR-29b), neurodegeneration-associated proteins (Aβ1–42, Tau), survival/inflammatory signaling pathways (p-Akt, PI3K mRNA, ERK, Bcl-2, COX2, IL-1β, TNF-α, IL-2, TGF-β), apoptosis (Caspase-3), BDNF mRNA, and brain histology. Maternal ZnO NP exposure significantly reduced offspring brain weight, body weight, and survival index, particularly following combined gestational and lactational exposure. Exposed offspring brains exhibited increased oxidative stress, depleted antioxidant defenses, impaired AChE activity, global DNA hypomethylation with targeted BDNF promoter hypermethylation (correlating with reduced BDNF mRNA), increased Aβ1–42 and Tau accumulation, suppressed PI3K/p-Akt and ERK survival signaling, elevated pro-inflammatory markers (IL-1β, TNF-α, IL-2, COX2, TGF-β), increased apoptosis (Caspase-3) alongside decreased Bcl-2, and dysregulated miRNA expression (increased miR-34a, decreased miR-29b). Histology confirmed duration-dependent neuronal damage. Maternal ZnO NP exposure induces persistent offspring neurotoxicity via oxidative stress, neuroinflammation, apoptosis, and epigenetic dysregulation. This highlights developmental brain vulnerability and the importance of assessing maternal nanoparticle exposure. Graphical abstract
- Open Access
- 16 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Date seeds powder alleviate the aflatoxin B1 provoked heart toxicity in male offspring rat
Date (Phoenix dactylifera L.) seeds (PDL) have recently evoked significant attention for their therapeutic potential against numerous diseases. Aflatoxin B1 (AFB1) is an inevitable environmental hazard that pollutes foods and may harm the heart. This study investigated the beneficial effect of PDL against cardiac toxicity induced by AFB1 in male offspring. Female albino rats received PDL (200 mg/kg) orally for 14 days before mating till weaning and AFB1 (50 μg/kg) intramuscularly throughout gestation and lactation. At postnatal day 60, male offspring hearts were collected. Compared to AFB1 intoxicated group, PDL-treated offspring displayed improved cardiac biomarkers, an increase in their antioxidant defense, and a decrease in the cardiac proinflammatory cytokines. Additionally, a reduction in the expression levels of Bcl2 and Nrf2 was observed, with genes linked to increased cardiac caspase-3, Bax, ACE1, P53, and cytochrome C levels. In conclusion, PDL acts as a potential adjuvant agent for ameliorating cardiac toxicity and apoptosis resulting from exposure to AFB1. This is attributed to its antioxidative and anti-inflammatory effects, as well as its capacity to sequester free radicals within cardiac tissue.
- 16 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Open AccessDate seeds powder alleviate the aflatoxin B1 provoked heart toxicity in male offspring rat
Date (Phoenix dactylifera L.) seeds (PDL) have recently evoked significant attention for their therapeutic potential against numerous diseases. Aflatoxin B1 (AFB1) is an inevitable environmental hazard that pollutes foods and may harm the heart. This study investigated the beneficial effect of PDL against cardiac toxicity induced by AFB1 in male offspring. Female albino rats received PDL (200 mg/kg) orally for 14 days before mating till weaning and AFB1 (50 μg/kg) intramuscularly throughout gestation and lactation. At postnatal day 60, male offspring hearts were collected. Compared to AFB1 intoxicated group, PDL-treated offspring displayed improved cardiac biomarkers, an increase in their antioxidant defense, and a decrease in the cardiac proinflammatory cytokines. Additionally, a reduction in the expression levels of Bcl2 and Nrf2 was observed, with genes linked to increased cardiac caspase-3, Bax, ACE1, P53, and cytochrome C levels. In conclusion, PDL acts as a potential adjuvant agent for ameliorating cardiac toxicity and apoptosis resulting from exposure to AFB1. This is attributed to its antioxidative and anti-inflammatory effects, as well as its capacity to sequester free radicals within cardiac tissue.
- Open Access
Hypericum perforatum L. Nanoemulsion Mitigates Cisplatin-Induced Chemobrain via Reducing Neurobehavioral Alterations, Oxidative Stress, Neuroinflammation, and Apoptosis in Adult Rats
Cisplatin (Cis) is a potent chemotherapeutic agent; however, it is linked with oxidative stress, inflammation, and apoptosis, which may harmfully affect the brain. Hypericum perforatum L. (HP L.) is a strong medicinal plant, but its hydrophobic polyphenolic compounds limit its activity. Therefore, our study aimed to investigate the neuroprotective action of HP L. and its nanoemulsion (NE) against Cis-induced neurotoxicity. The prepared HP.NE was subjected to characterization. The droplet size distribution, surface charge, and morphology were evaluated. In addition, an in vitro dissolution study was conducted. Compared to Cis-intoxicated rats, HP L. and HP.NE-treated rats displayed improved motor activity and spatial working memory. They also showed an increase in their antioxidant defense system and a reduction in the levels of pro-inflammatory cytokines in the brain. Moreover, they showed an increase in the expression levels of the PON-3 and GPX genes, which are associated with a reduction in the brain levels of COX-2 and TP-53. These findings were confirmed by reducing the immunohistochemical expression of nuclear factor kappa (NF-ƘB) and enhanced Ki-67 levels. In conclusion, HP L. is a promising herb and could be used as an adjuvant candidate to ameliorate chemotherapeutic-induced neurotoxicity. Moreover, HP.NE has superior activity in lessening Cis-induced oxidative stress, inflammation, and apoptosis in brain tissue.
Open AccessHypericum perforatum L. Nanoemulsion Mitigates Cisplatin-Induced Chemobrain via Reducing Neurobehavioral Alterations, Oxidative Stress, Neuroinflammation, and Apoptosis in Adult Rats
Cisplatin (Cis) is a potent chemotherapeutic agent; however, it is linked with oxidative stress, inflammation, and apoptosis, which may harmfully affect the brain. Hypericum perforatum L. (HP L.) is a strong medicinal plant, but its hydrophobic polyphenolic compounds limit its activity. Therefore, our study aimed to investigate the neuroprotective action of HP L. and its nanoemulsion (NE) against Cis-induced neurotoxicity. The prepared HP.NE was subjected to characterization. The droplet size distribution, surface charge, and morphology were evaluated. In addition, an in vitro dissolution study was conducted. Compared to Cis-intoxicated rats, HP L. and HP.NE-treated rats displayed improved motor activity and spatial working memory. They also showed an increase in their antioxidant defense system and a reduction in the levels of pro-inflammatory cytokines in the brain. Moreover, they showed an increase in the expression levels of the PON-3 and GPX genes, which are associated with a reduction in the brain levels of COX-2 and TP-53. These findings were confirmed by reducing the immunohistochemical expression of nuclear factor kappa (NF-ƘB) and enhanced Ki-67 levels. In conclusion, HP L. is a promising herb and could be used as an adjuvant candidate to ameliorate chemotherapeutic-induced neurotoxicity. Moreover, HP.NE has superior activity in lessening Cis-induced oxidative stress, inflammation, and apoptosis in brain tissue.